---
title: "UBS Reaffirms Their Hold Rating on Sundrug Co (SDGCF)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291930037.md"
description: "In a report released today, from UBS maintained a Hold rating on Sundrug Co, with a price target of Yen3,970.00.4th of July Sale - 70% Off Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. Currently, the analyst consensus on Sundrug Co is a Hold with an average price target of Yen4,423.60."
datetime: "2026-07-07T12:05:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291930037.md)
  - [en](https://longbridge.com/en/news/291930037.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291930037.md)
generator: "portal-rs"
---

# UBS Reaffirms Their Hold Rating on Sundrug Co (SDGCF)

In a report released today, from UBS maintained a Hold rating on Sundrug Co, with a price target of Yen3,970.00.

### 4th of July Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

Currently, the analyst consensus on Sundrug Co is a Hold with an average price target of Yen4,423.60.

### Related Stocks

- [9989.JP](https://longbridge.com/en/quote/9989.JP.md)
- [UBS.US](https://longbridge.com/en/quote/UBS.US.md)

## Related News & Research

- [Japan aims to cap FY27 new bond issuance at 40 trillion yen, PM says in Yomiuri interview](https://longbridge.com/en/news/297269452.md)
- [Protagonist Therapeutics Announces U.S. FDA Approval of Hepcidin Mimetic Peptide MIMRYLO(TM) (rusfertide) for Polycythemia Vera](https://longbridge.com/en/news/297376639.md)
- [REG - Tungsten West PLC - Short-Term Loan Repayment](https://longbridge.com/en/news/297279092.md)
- [Trump reputation with ranchers has 'taken a hit': Cattlemen's Association chief](https://longbridge.com/en/news/297070428.md)
- [EU Commission grants Lundbeck orphan drug status for asedebart in endogenous Cushing’s syndrome](https://longbridge.com/en/news/296747576.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**